LPCN Lipocine Inc.
$2.27▲ +0.89%
Healthcare
Other
After hours
$2.27▲ +0.89%
Sep 11, 4:10 PM ET
Volume 10.3K
Avg Volume (10D) 21.8K
Key Metrics & Fundamentals
Market Cap
$18.71M
P/E Ratio
–
Div Yield
–%
52W Range
1.81 - 12.37
% vs 50 MA
2.55%
% vs 200 MA
-49.39%
RSI-14
53.4
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.43
Free Cash Flow
-$3.03M
Gross Rev
$190,099
Gross Profit
-$1.85M
EBITDA
-$2.83M
COGS
$2.04M
Operating Exp
$990,956
Operating Income
-$2.84M
EBIT
-$2.84M
Pretax Income
-$2.62M
Net Income
-$2.62M
EPS (Diluted)
-0.32
Price & Volume History
Loading chart…
Recent News
Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · Sep 10, 2026 12:00 PM
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026
PR Newswire · Aug 4, 2026 12:00 PM
Lipocine: Q2 Earnings Snapshot
Associated Press · Aug 4, 2026 10:21 AM
Lipocine Appoints Michael J. Grissinger to Board of Directors
PR Newswire · Aug 3, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See LPCN's money flow as a full page
Social Sentiment
No Reddit posts found for LPCN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.